FCMI

Foresite Capital Management IV Portfolio holdings

AUM $124M
1-Year Est. Return 24.36%
This Quarter Est. Return
1 Year Est. Return
-24.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$443M
AUM Growth
+$238M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
19
New
Increased
Reduced
Closed

Top Buys

1
+$91.1M
2
+$82M
3
+$36.7M
4
ABUS icon
Arbutus Biopharma
ABUS
+$10.4M
5
PNT
POINT Biopharma Global Inc. Common Stock
PNT
+$5.03M

Top Sells

1
+$20.7M
2
+$7.65M
3
+$7.65M
4
ORIC icon
Oric Pharmaceuticals
ORIC
+$4.22M
5
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$635K

Sector Composition

1 Healthcare 99.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$91.1M 20.55%
+2,139,380
2
$82M 18.48%
+2,348,014
3
$54.5M 12.29%
1,412,705
-15,366
4
$40.1M 9.04%
1,307,982
5
$36.7M 8.29%
+973,514
6
$36.2M 8.16%
1,672,292
+65,000
7
$26.5M 5.98%
85,794
8
$23M 5.19%
465,821
-155,000
9
$17.2M 3.89%
126,492
10
$12.9M 2.92%
1,787,094
-1,056,799
11
$10.4M 2.35%
+3,332,616
12
$5.51M 1.24%
516,751
13
$5.03M 1.14%
+350,000
14
$1.8M 0.41%
+150,000
15
$372K 0.08%
+144,874
16
– –
-1,133,948
17
– –
-125,000
18
– –
-30,000
19
– –
-25,000